Literature DB >> 35077767

The Two Non-Visual Arrestins Engage ERK2 Differently.

Nicole A Perry-Hauser1, Jesse B Hopkins2, Ya Zhuo3, Chen Zheng4, Ivette Perez5, Kathryn M Schultz3, Sergey A Vishnivetskiy4, Ali I Kaya4, Pankaj Sharma4, Kevin N Dalby6, Ka Young Chung7, Candice S Klug3, Vsevolod V Gurevich8, T M Iverson9.   

Abstract

Arrestin binding to active phosphorylated G protein-coupled receptors terminates G protein coupling and initiates another wave of signaling. Among the effectors that bind directly to receptor-associated arrestins are extracellular signal-regulated kinases 1/2 (ERK1/2), which promote cellular proliferation and survival. Arrestins may also engage ERK1/2 in isolation in a pre- or post-signaling complex that is likely in equilibrium with the full signal initiation complex. Molecular details of these binary complexes remain unknown. Here, we investigate the molecular mechanisms whereby arrestin-2 and arrestin-3 (a.k.a. β-arrestin1 and β-arrestin2, respectively) engage ERK1/2 in pairwise interactions. We find that purified arrestin-3 binds ERK2 more avidly than arrestin-2. A combination of biophysical techniques and peptide array analysis demonstrates that the molecular basis in this difference of binding strength is that the two non-visual arrestins bind ERK2 via different parts of the molecule. We propose a structural model of the ERK2-arrestin-3 complex in solution using size-exclusion chromatography coupled to small angle X-ray scattering (SEC-SAXS). This binary complex exhibits conformational heterogeneity. We speculate that this drives the equilibrium either toward the full signaling complex with receptor-bound arrestin at the membrane or toward full dissociation in the cytoplasm. As ERK1/2 regulates cell migration, proliferation, and survival, understanding complexes that relate to its activation could be exploited to control cell fate.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  arrestin; extracellular signal-regulated kinase 2; protein scaffolds; protein–protein interactions; small-angle X-ray scattering

Mesh:

Substances:

Year:  2022        PMID: 35077767      PMCID: PMC8977243          DOI: 10.1016/j.jmb.2022.167465

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  82 in total

1.  Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation.

Authors:  M Han; V V Gurevich; S A Vishnivetskiy; P B Sigler; C Schubert
Journal:  Structure       Date:  2001-09       Impact factor: 5.006

Review 2.  'Location, location, location': activation and targeting of MAP kinases by G protein-coupled receptors.

Authors:  L M Luttrell
Journal:  J Mol Endocrinol       Date:  2003-04       Impact factor: 5.098

3.  Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.

Authors:  L M Luttrell; S S Ferguson; Y Daaka; W E Miller; S Maudsley; G J Della Rocca; F Lin; H Kawakatsu; K Owada; D K Luttrell; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

4.  Activation loop dynamics are controlled by conformation-selective inhibitors of ERK2.

Authors:  Laurel M Pegram; Jennifer C Liddle; Yao Xiao; Maria Hoh; Johannes Rudolph; Dylan B Iverson; Guy P Vigers; Darin Smith; Hailong Zhang; Weiru Wang; John G Moffat; Natalie G Ahn
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-16       Impact factor: 11.205

5.  The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation.

Authors:  Sergio Coffa; Maya Breitman; Susan M Hanson; Kari Callaway; Seunghyi Kook; Kevin N Dalby; Vsevolod V Gurevich
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

6.  Improved radiation dose efficiency in solution SAXS using a sheath flow sample environment.

Authors:  Nigel Kirby; Nathan Cowieson; Adrian M Hawley; Stephen T Mudie; Duncan J McGillivray; Michael Kusel; Vesna Samardzic-Boban; Timothy M Ryan
Journal:  Acta Crystallogr D Struct Biol       Date:  2016-11-29       Impact factor: 7.652

7.  ATSAS 2.8: a comprehensive data analysis suite for small-angle scattering from macromolecular solutions.

Authors:  D Franke; M V Petoukhov; P V Konarev; A Panjkovich; A Tuukkanen; H D T Mertens; A G Kikhney; N R Hajizadeh; J M Franklin; C M Jeffries; D I Svergun
Journal:  J Appl Crystallogr       Date:  2017-06-26       Impact factor: 3.304

8.  An Eight Amino Acid Segment Controls Oligomerization and Preferred Conformation of the two Non-visual Arrestins.

Authors:  Qiuyan Chen; Ya Zhuo; Pankaj Sharma; Ivette Perez; Derek J Francis; Srinivas Chakravarthy; Sergey A Vishnivetskiy; Sandra Berndt; Susan M Hanson; Xuanzhi Zhan; Evan K Brooks; Christian Altenbach; Wayne L Hubbell; Candice S Klug; T M Iverson; Vsevolod V Gurevich
Journal:  J Mol Biol       Date:  2020-12-31       Impact factor: 5.469

9.  Manifold roles of β-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9.

Authors:  Louis M Luttrell; Jialu Wang; Bianca Plouffe; Jeffrey S Smith; Lama Yamani; Suneet Kaur; Pierre-Yves Jean-Charles; Christophe Gauthier; Mi-Hye Lee; Biswaranjan Pani; Jihee Kim; Seungkirl Ahn; Sudarshan Rajagopal; Eric Reiter; Michel Bouvier; Sudha K Shenoy; Stéphane A Laporte; Howard A Rockman; Robert J Lefkowitz
Journal:  Sci Signal       Date:  2018-09-25       Impact factor: 9.517

10.  Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.

Authors:  Jihee Kim; Seungkirl Ahn; Keshava Rajagopal; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2009-03-02       Impact factor: 5.157

View more
  3 in total

Review 1.  Solo vs. Chorus: Monomers and Oligomers of Arrestin Proteins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

2.  GPCR-mediated β-arrestin activation deconvoluted with single-molecule precision.

Authors:  Wesley B Asher; Daniel S Terry; G Glenn A Gregorio; Alem W Kahsai; Alessandro Borgia; Bing Xie; Arnab Modak; Ying Zhu; Wonjo Jang; Alekhya Govindaraju; Li-Yin Huang; Asuka Inoue; Nevin A Lambert; Vsevolod V Gurevich; Lei Shi; Robert J Lefkowitz; Scott C Blanchard; Jonathan A Javitch
Journal:  Cell       Date:  2022-04-27       Impact factor: 66.850

3.  Short Arrestin-3-Derived Peptides Activate JNK3 in Cells.

Authors:  Nicole A Perry-Hauser; Tamer S Kaoud; Henriette Stoy; Xuanzhi Zhan; Qiuyan Chen; Kevin N Dalby; Tina M Iverson; Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Int J Mol Sci       Date:  2022-08-04       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.